These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17908651)

  • 1. The clinical manifestations and risk factors of a delayed diagnosis of Kawasaki disease.
    Juan CC; Hwang B; Lee PC; Lin YJ; Chien JC; Lee HY; Meng CC
    J Chin Med Assoc; 2007 Sep; 70(9):374-9. PubMed ID: 17908651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed diagnosis of Kawasaki syndrome: an analysis of the problem.
    Anderson MS; Todd JK; Glodé MP
    Pediatrics; 2005 Apr; 115(4):e428-33. PubMed ID: 15805345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed diagnosis of Kawasaki disease: risk factors and outcome of treatment.
    Sittiwangkul R; Pongprot Y; Silvilairat S; Phornphutkul C
    Ann Trop Paediatr; 2011; 31(2):109-14. PubMed ID: 21575314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with delay in diagnosis of Kawasaki disease in India.
    Balasubramanian S; Krishna MR; Dhanalakshmi K; Amperayani S; Ramanan AV
    Indian Pediatr; 2012 Aug; 49(8):663-5. PubMed ID: 22962240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early diagnosis of Kawasaki disease complicated by coronary artery lesions].
    Hu XH; Xu SX; Luan Z
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):853-5. PubMed ID: 12919919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
    Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otorhinolaryngological manifestations and delayed diagnosis in Kawasaki disease.
    Rouault M; Coudert A; Hermann R; Gillet Y; Truy E; Ayari-Khalfallah S
    Int J Pediatr Otorhinolaryngol; 2019 Jun; 121():137-142. PubMed ID: 30903929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS; Knezovic I; Papic N; Mise B; Roglic S; Markovinovic L; Tesovic G
    Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
    Song D; Yeo Y; Ha K; Jang G; Lee J; Lee K; Son C; Lee J
    Eur J Pediatr; 2009 Nov; 168(11):1315-21. PubMed ID: 19159953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
    Satoh K; Wakejima Y; Gau M; Kiguchi T; Matsuda N; Takasawa R; Takasawa K; Nishioka M; Shimohira M
    Int J Rheum Dis; 2018 Mar; 21(3):746-754. PubMed ID: 29105337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effective use of echocardiography in children with Kawasaki disease.
    Scott JS; Ettedgui JA; Neches WH
    Pediatrics; 1999 Nov; 104(5):e57. PubMed ID: 10545583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kawasaki disease in children and adolescents: clinical data of Kawasaki patients in a western region (Tyrol) of Austria from 2003-2012.
    Binder E; Griesmaier E; Giner T; Sailer-Höck M; Brunner J
    Pediatr Rheumatol Online J; 2014 Sep; 12(1):37. PubMed ID: 27643389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Symptoms, diagnosis and characteristic abnormalities in the coronary arteries in Kawasaki disease in children].
    Kowalczyk M; Turska-Kmieć A; Ziółkowska L; Raszek M; Kawalec W
    Med Wieku Rozwoj; 2010; 14(4):344-9. PubMed ID: 21462478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Kawasaki Disease: A Single-Center Experience.
    Uysal F; Bostan OM; Celebi S; Uysal B; Hamitoglu S; Cil E
    Clin Pediatr (Phila); 2015 Jun; 54(6):579-84. PubMed ID: 25475592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical spectrum of incomplete Kawasaki disease in Thailand.
    Sittiwangkul R; Pongprot Y; Silvilairat S; Makonkaewkeyoon K
    Paediatr Int Child Health; 2013 Aug; 33(3):176-80. PubMed ID: 23930731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Kawasaki disease in older children.
    Cai Z; Zuo R; Liu Y
    Clin Pediatr (Phila); 2011 Oct; 50(10):952-6. PubMed ID: 21628347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of Kawasaki Disease in Adolescents: Is It Different?
    Advani N; Santoso LA; Sastroasmoro S
    Acta Med Indones; 2019 Jan; 51(1):42-46. PubMed ID: 31073105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.